# Guardian Pharmacy Services, Inc. (GRDN) · Edgar & Edgarette company card

> Guardian Pharmacy Services (GRDN) grew revenue 17.9% in FY2025 to $1.4 billion, operating margin 5.0% against a 0.6% median for drug stores and proprietary stores, equity 52.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 1802255 · fiscal year ended 2025-12-31 · 2 audited years read · [page](https://www.pops4.com/boards/company/GRDN) · [JSON](https://www.pops4.com/boards/company/GRDN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $1.4B |
| Revenue growth, 1 year | 17.9% |
| Revenue growth per year | — |
| Operating margin | 5.0% (prior year -5.1%) |
| Net margin | 3.4% |
| Operating cash flow | $100M |
| Capital spending | $13M |
| Free cash flow | $87M |
| Cash | $66M |
| Long-term debt | $0 |
| Total assets | $413M |
| Total equity | $218M |
| Equity ÷ assets | 52.8% |
| Return on equity | 22.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: 3.85 (safe zone)
- Piotroski F: 6 of 9 (solid)
- Beneish M: -2.95 (below the −1.78 line)
- Health Harbor boat: New ship · no warning signs

## Edgarette's reading

Exposure: revenue $1.4B (FY2025), total debt $0K. Experience: revenue up 17.9% on the year; operating margin 5.0%, up from -5.1%. Soundness: equity 52.8% of assets, return on equity 22.6%. Credibility: 2 audited years, moderate weight. Range: 80% of past cases like this landed between $1.4B and $2.0B next year (method v3, set from 4,599 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (57 filers, $50M+ revenue, its industry group): operating margin 5.0% against a 0.6% median; growth 17.9% against 4.1%.

Range logged 2026-09-20, receipt d1a57a8a1b74b96e, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-06-22 ([filing](https://www.sec.gov/Archives/edgar/data/1802255/000119312526277596/0001193125-26-277596-index.htm))

## Recent filings

- 8-K · filed 2026-09-10 · 8.01 Other Events · [filing](https://www.sec.gov/Archives/edgar/data/1802255/000119312526387858/0001193125-26-387858-index.htm)
- 10-Q · filed 2026-08-06 · [filing](https://www.sec.gov/Archives/edgar/data/1802255/000119312526338074/0001193125-26-338074-index.htm)
- 8-K · filed 2026-08-06 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1802255/000119312526338032/0001193125-26-338032-index.htm)
- 8-K · filed 2026-06-22 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1802255/000119312526277596/0001193125-26-277596-index.htm)
- 8-K · filed 2026-05-28 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/1802255/000119312526245235/0001193125-26-245235-index.htm)
- 8-K · filed 2026-05-07 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/1802255/000119312526211924/0001193125-26-211924-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0001802255.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1802255

## Cite

POPS4, Edgar & Edgarette: Guardian Pharmacy Services, Inc. (GRDN) company card, from the company's own SEC filings, accessed 2026-11-04, https://www.pops4.com/boards/company/GRDN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.